Page last updated: 2024-11-02

piracetam and End Stage Liver Disease

piracetam has been researched along with End Stage Liver Disease in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.

Research Excerpts

ExcerptRelevanceReference
" The dosage of immunosuppressants did not change before and after levetiracetam treatment, and there were no changes in hematological and biochemical data before and after treatment."5.42Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation. ( Chen, CL; Chen, NC; Chuang, YC; Lin, CH; Lin, TK; Tsai, MH, 2015)
" The dosage of immunosuppressants did not change before and after levetiracetam treatment, and there were no changes in hematological and biochemical data before and after treatment."1.42Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation. ( Chen, CL; Chen, NC; Chuang, YC; Lin, CH; Lin, TK; Tsai, MH, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, CH1
Chen, CL1
Lin, TK1
Chen, NC1
Tsai, MH1
Chuang, YC1

Other Studies

1 other study available for piracetam and End Stage Liver Disease

ArticleYear
Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation.
    Medicine, 2015, Volume: 94, Issue:38

    Topics: Adult; Anticonvulsants; Drug Monitoring; End Stage Liver Disease; Female; Humans; Levetiracetam; Liv

2015